{"result": "(\"entity\"<|>ADENOMAS HIPOFISARIOS<|>ORGANIZATION<|>Adenomas hipofisarios are pituitary tumors that can produce prolactin, leading to hyperprolactinemia and associated symptoms.)\n##\n(\"entity\"<|>CARCINOMA BRONCOGÉNICO<|>ORGANIZATION<|>Carcinoma broncogénico is a type of lung cancer that can cause ectopic production of prolactin, contributing to hyperprolactinemia.)\n##\n(\"entity\"<|>CARCINOMA DE CÉLULAS RENALES<|>ORGANIZATION<|>Carcinoma de células renales is a kidney cancer that can also lead to ectopic prolactin production, affecting prolactin levels in the body.)\n##\n(\"entity\"<|>HIPOYTHYROIDISMO PRIMARIO<|>EVENT<|>Hipotiroidismo primario is a condition that can be associated with hyperprolactinemia and galactorrhea due to increased TRH levels.)\n##\n(\"entity\"<|>SÍNDROME DE OVARIO POLIQUÍSTICO<|>EVENT<|>Síndrome de ovario poliquístico is a condition that can lead to hormonal imbalances, including hyperprolactinemia.)\n##\n(\"entity\"<|>ENFERMEDADES INFILTRATIVAS DEL HIPOTÁLAMO<|>EVENT<|>Enfermedades infiltrativas del hipotálamo are conditions that can affect the hypothalamus and lead to increased prolactin levels.)\n##\n(\"entity\"<|>CIRROSIS HEPÁTICA<|>EVENT<|>Cirrosis hepática is a liver disease that can impact hormone levels, including prolactin.)\n##\n(\"entity\"<|>ENFERMEDAD RENAL CRÓNICA<|>EVENT<|>Enfermedad renal crónica is a chronic kidney disease that can lead to alterations in prolactin clearance.)\n##\n(\"entity\"<|>MACROPROLACTINEMIA<|>EVENT<|>Macroprolactinemia is a condition characterized by high levels of macroprolactin, which can lead to symptoms similar to hyperprolactinemia.)\n##\n(\"entity\"<|>MUTACIONES GERMINALES<|>EVENT<|>Mutaciones germinales are genetic mutations that can affect the prolactin receptor, leading to hyperprolactinemia.)\n##\n(\"entity\"<|>ALTERACIONES ENDOCRINOLÓGICAS<|>EVENT<|>Alteraciones endocrinológicas refer to various hormonal imbalances that can lead to conditions like hyperprolactinemia.)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>ADENOMAS HIPOFISARIOS<|>Adenomas hipofisarios are a common cause of hyperprolactinemia due to their ability to produce prolactin.<|>8)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>CARCINOMA BRONCOGÉNICO<|>Carcinoma broncogénico can lead to ectopic production of prolactin, contributing to hyperprolactinemia.<|>6)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>CARCINOMA DE CÉLULAS RENALES<|>Carcinoma de células renales can also cause ectopic prolactin production, affecting prolactin levels.<|>6)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>HIPOYTHYROIDISMO PRIMARIO<|>Hipotiroidismo primario can be associated with hyperprolactinemia due to increased TRH levels.<|>7)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>SÍNDROME DE OVARIO POLIQUÍSTICO<|>Síndrome de ovario poliquístico can lead to hormonal imbalances, including hyperprolactinemia.<|>5)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>ENFERMEDADES INFILTRATIVAS DEL HIPOTÁLAMO<|>Enfermedades infiltrativas del hipotálamo can affect hormone levels, leading to hyperprolactinemia.<|>5)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>CIRROSIS HEPÁTICA<|>Cirrosis hepática can impact hormone levels, including prolactin, contributing to hyperprolactinemia.<|>5)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>ENFERMEDAD RENAL CRÓNICA<|>Enfermedad renal crónica can lead to alterations in prolactin clearance, affecting hyperprolactinemia levels.<|>5)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>MACROPROLACTINEMIA<|>Macroprolactinemia can present symptoms similar to hyperprolactinemia, linking the two conditions.<|>4)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>MUTACIONES GERMINALES<|>Mutaciones germinales can lead to hyperprolactinemia due to receptor insensitivity.<|>6)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>ALTERACIONES ENDOCRINOLÓGICAS<|>Alteraciones endocrinológicas can lead to hormonal imbalances, including hyperprolactinemia.<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: la 3. Causas no fisiológicas de hiperprolactinemia\n        tratamiento farmacológico o en mujeres con prolactinomas gigantes y deseo de gestación (por\n        el riesgo de crecimiento del prolactinoma durante el embarazo al reducir/discontinuar los ago-                                           Aumento de                     • Adenomas hipofisarios productores de prolactina (prolactinomas,\n        nistas dopaminérgicos) (respuesta C verdadera).                                                                                          secreción de PRL                 acromegalia, tumores plurihormonales)\n                                                                                                                                                                                • Producción ectópica de PRL: carcinoma broncogénico o carcinoma de\n        Referencias:                                                                                                                                                              células renales\n        • Melmed S, Kleinberg DL. Adenohipófisis. En: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams Tratado                     Reducción de                   • Tumores: adenomas hipofisarios (no lactotropos), craneofaringiomas,\n          de Endocrinología. Versión en español de la 10.ª edición de la obra original en inglés. Madrid: Elsevier España; 2004. p. 193-306.\n        • Snyder PJ. Causes of hyperprolactinemia. En: Cooper DS, Martin KA, eds. UpToDate. Waltham, MA: UpToDate Inc.                           la inhibición                    germinomas, meningiomas o metástasis\n          https://www.uptodate.com (acceso el 29 de abril de 2019).                                                                              dopaminérgica                  • Enfermedades infiltrativas del hipotálamo (p. ej., tuberculosis,\n        • Snyder PJ. Clinical manifestations and evaluation of hyperprolactinemia. En: Cooper DS, Martin KA, eds. UpToDate.                      de la PRL                        histiocitosis X, sarcoidosis)\n          Waltham, MA: UpToDate Inc. https://www.uptodate.com (acceso 29 de abril de 2019).\n        • Snyder PJ. Management of hyperprolactinemia. En: Cooper DS, Martin KA, eds. UpToDate. Waltham, MA: UpToDate Inc.                                                      • Sección del tallo hipofisario (traumática o posquirúrgica, por ejemplo)\n          https://www.uptodate.com (acceso 29 de abil de 2019).                                                                                                                 • Irradiación de la región hipotálamo-hipofisaria\n                                                                                                                                                                                • Cirrosis hepática alcohólica y no alcohólica\n    27  Entre las causas          posibles de galactorrea se encuentran                       las siguientes, excepto:                           Disminución del                • Enfermedad renal crónica\n                                                                                                                                                 aclaramiento de PRL            • Macroprolactinemia\n        A. Hipertiroidismo.                                                                                                                      Mecanismo neural               • Daño en la pared torácica (quemaduras, herpes zóster, traumatismos o\n        B. Tratamiento con paroxetina.                                                                                                                                            cirugía)\n        C. Tratamiento con antagonistas del calcio.                                                                                              Genéticas                      • Mutaciones germinales de pérdida de función en el gen del receptor de\n        D.  Producción ectópica de prolactina por un carcinoma broncogénico.                                                                                                      PRL (asocian hiperprolactinemia con insensibilidad a la PRL en algunos\n                                                                                                                                                                                  tejidos, pero síntomas derivados de exceso de PRL en otros tejidos que\n                                                                                                                                                                                  pueden mantener receptores funcionantes de PRL)\n        COMENTARIO                                                                                                                               Alteraciones                   • Hipotiroidismo primario\n        La galactorrea se         define como la secreción            láctea mamaria,         fuera del     proceso del pre-pos-                 endocrinológicas               • Insuficiencia adrenal\n        parto. Es una alteración frecuente en las mujeres en edad reproductiva y es fundamental                                                                                 • Síndrome de ovario poliquístico\n        su diagnóstico etiológico.                                                                                                               Hiperprolactinemia             • En torno al 15% (en series antiguas se daban cifras más altas, pero cada\n        La causa más frecuente de galactorrea es la                     hiperprolactinemia (patológica o farmacológi-                            idiopática                       vez se reconoce mejor la etiología)\n        ca),  aunque existen         casos de galactorrea sin hiperprolactinemia asociada.                                                    El hipotiroidismo primario (y no el hipertiroidismo, como afirma la respuesta A) se puede\n        La hiperprolactinemia de origen farmacológico es la más habitual. Destacan como fárma-                                                asociar a hiperprolactinemia y galactorrea. La TRH es un potente factor estimulante de la\n        cos asociados a hiperprolactinemia:                                                                                                   liberación de PRL. En el hipotiroidismo primario hay un aumento tanto en la síntesis de TRH\n        •  Antidepresivos: tricíclicos, inhibidores de la monoaminooxidasa o en menor grado inhibi-                                           como en la respuesta de la hipófisis a\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>UPTODATE INC.<|>ORGANIZATION<|>UpToDate Inc. is a medical resource providing clinical information and guidelines, including topics on hyperprolactinemia.)\n##\n(\"entity\"<|>ELSEVIER ESPAÑA<|>ORGANIZATION<|>Elsevier España is a publishing company that published the Spanish version of Williams Tratado de Endocrinología.)\n##\n(\"entity\"<|>WALTHAM<|>GEO<|>Waltham is a city in Massachusetts, USA, where UpToDate Inc. is located.)\n##\n(\"entity\"<|>HYPERPROLACTINEMIA<|>EVENT<|>Hyperprolactinemia is a medical condition characterized by elevated levels of prolactin in the blood, which can lead to various symptoms including galactorrhea.)\n##\n(\"entity\"<|>GALACTORRHEA<|>EVENT<|>Galactorrhea is the secretion of breast milk outside of the normal breastfeeding process, often associated with hyperprolactinemia.)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Samuel Namara is a fictional character mentioned in the context of being a hostage, but not directly related to the medical context of the text.)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Durke Bataglani is another fictional character mentioned in the context of being a hostage, but not directly related to the medical context of the text.)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Meggie Tazbah is a fictional character mentioned in the context of being a hostage, but not directly related to the medical context of the text.)\n##\n(\"relationship\"<|>UPTODATE INC.<|>ELSEVIER ESPAÑA<|>Both organizations are involved in the publication and dissemination of medical knowledge, including information on hyperprolactinemia.<|>6)\n##\n(\"relationship\"<|>HYPERPROLACTINEMIA<|>GALACTORRHEA<|>Hyperprolactinemia is a common cause of galactorrhea, linking the two medical conditions.<|>8)\n<|COMPLETE|>"}]}